Your browser doesn't support javascript.
loading
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.
Kindler, H L; Richards, D A; Garbo, L E; Garon, E B; Stephenson, J J; Rocha-Lima, C M; Safran, H; Chan, D; Kocs, D M; Galimi, F; McGreivy, J; Bray, S L; Hei, Y; Feigal, E G; Loh, E; Fuchs, C S.
Afiliación
  • Kindler HL; Section of Hematology/Oncology, University of Chicago Medical Center, Chicago. Electronic address: hkindler@medicine.bsd.uchicago.edu.
  • Richards DA; US Oncology Research, Tyler.
  • Garbo LE; US Oncology Research, Houston.
  • Garon EB; David Geffen School of Medicine at University of California Los Angeles/Translational Oncology Research International Network, Los Angeles.
  • Stephenson JJ; Department of Experimental Therapeutics, Greenville Hospital System University Medical Center, Greenville.
  • Rocha-Lima CM; Department of Medicine, University of Miami/Sylvester Comprehensive Cancer Center, Miami.
  • Safran H; The Brown University Oncology Group, Rhode Island Hospital, Providence.
  • Chan D; Cancer Care Associates Medical Group, Inc., Redondo Beach.
  • Kocs DM; US Oncology Research, Round Rock.
  • Galimi F; Global Development, Amgen Inc., Thousand Oaks.
  • McGreivy J; Global Development, Amgen Inc., South San Francisco, USA.
  • Bray SL; Department of Biostatistics and Epidemiology, Amgen Ltd, Cambridge, UK.
  • Hei Y; Global Development, Amgen Inc., Thousand Oaks.
  • Feigal EG; Global Development, Amgen Inc., Thousand Oaks.
  • Loh E; Global Development, Amgen Inc., South San Francisco, USA.
  • Fuchs CS; Department of Medical Oncology/Solid Tumor Oncology, Dana-Farber Cancer Institute, Boston, USA.
Ann Oncol ; 23(11): 2834-2842, 2012 Nov.
Article en En | MEDLINE | ID: mdl-22700995
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Desoxicitidina / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2012 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Desoxicitidina / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2012 Tipo del documento: Article